Abstract
Prostate cancer recurrence after radiation therapy might be cured with different treatment modalities (radical prostatectomy, HIFU, cryotherapy). All whole-gland salvage therapy approaches carry the potential of serious morbidity from the development of urethro-rectal fistula, severe urinary incontinence, and urethral stenosis.
Focal salvage HIFU (FSH) represents a new therapeutic option with the aim to destroy the recurrent tumor with minimal risk of severe side effects. The initial results of this new treatment approach were recently published. Focal salvage HIFU is feasible in different clinical situations with less severe morbidity than whole-gland salvage therapies and may preserve pretreatment QoL. Patient selection, accurate imaging, and biopsy are essential to identify malignancy suitable for focal HIFU.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Chade DC, Shariat SF, Cronin AM, Savage CJ, Karnes RJ, Blute ML, et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol. 2011;60(2):205–10.
Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol. 2009;55(3):640–7.
Crouzet S, Murat FJ, Pommier P, Poissonnier L, Pasticier G, Rouviere O, et al. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes. Radiother Oncol. 2012;105(2):198–202.
Uddin Ahmed H, Cathcart P, Chalasani V, Williams A, McCartan N, Freeman A, et al. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy. Cancer. 2012;118(12):3071–8.
Mouraviev V, Spiess PE, Jones JS. Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy. Eur Urol. 2012;61(6):1204–11.
Ahmed HU, Cathcart P, McCartan N, Kirkham A, Allen C, Freeman A, et al. Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study. Cancer. 2012;118(17):4148–55.
Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, et al. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study. BJU Int. 2014;114(4):532–40.
Nguyen PL, D'Amico AV, Lee AK, Suh WW. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer. 2007;110(7):1417–28.
Heidenreich A, Richter S, Thuer D, Pfister D. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur Urol. 2010;57(3):437–43.
Chaussy C, Thuroff S, Bergsdorf T. Local recurrence of prostate cancer after curative therapy. HIFU (Ablatherm) as a treatment option. Urologe A. 2006;45(10):1271–5.
Hayashi M, Shinmei S, Asano K. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Int J Urol. 2007;14(11):1048–50.
Chaussy CG, Thuroff SF. Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use? Curr Urol Rep. 2011;12(3):180–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Crouzet, S. (2015). Salvage Focal HIFU. In: Thüroff, S., Chaussy, C. (eds) Focal Therapy of Prostate Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-14160-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-14160-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14159-6
Online ISBN: 978-3-319-14160-2
eBook Packages: MedicineMedicine (R0)